(Q34297736)

1 August 2017

1 reference

title

Protection against ischemia: a physiological function of the renin-angiotensin system (English)

1 reference

1 August 2017

Achard J

1

1 reference

1 August 2017

Fournier A

2

1 reference

1 August 2017

Mazouz H

3

1 reference

1 August 2017

Caride VJ

4

1 reference

1 August 2017

Penar PL

5

1 reference

1 August 2017

Fernandez LA

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

published in

Biochemical Pharmacology

1 reference

1 August 2017

volume

62

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

261-271

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

1 August 2017

1 reference

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The experimental observation that led to discovery of angiotensin. 1939 Buenos Aires, Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Hypertension research. A memoir 1920-1960.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Circulating and tissue angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Important role for angiotensin III and IV in the brain renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Preliminary biochemical characterization of two angiotensin II receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Binding characteristics and vascular effects of various angiotensin II antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

On the relationship of brain vasculature to production of neurological deficit and morphological changes following acute unilateral common carotid artery ligation in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Differences in mortality rate between abrupt and progressive carotid ligation in the gerbil: role of endogenous angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin AT2 receptor stimulation increases survival in gerbils with abrupt unilateral carotid ligation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Emerging features of brain angiotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Expression of a novel non-angiotensin II [125I]CGP 42112 binding site in healing wounds of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Increased non-angiotensin II [125I]CGP 42112 binding in rat carotid artery after balloon injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

"Reverse coronary steal" induced by coronary vasoconstriction following coronary artery occlusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Attenuation of myocardial stunning by the AT1 receptor antagonist candesartan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

[Expression of angiotensin type-2 receptors in rat brain during the cell injury]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The angiotensin type 2 receptor: variations on an enigmatic theme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II type 2 receptor mediates programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Time course of increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Collateral vessel formation: isolation of a transferable factor promoting a vascular response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II and retinal pericytes migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The renin-angiotensin system and vascular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin stimulation of bovine adrenocortical cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Opposing actions of angiotensin II on microvascular growth and arterial blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Opposing actions of angiotensins on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

The microcirculation in experimental hypertension and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Life and death in the microcirculation: a role for angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Reversal of microvascular rarefaction and reduced renal mass hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiogenesis and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II increases erythropoietin production in healthy human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Renin in glioblastoma multiforme and its role in neovascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiotensin II type 1 receptor expression in human breast tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Tumor dormancy in vivo by prevention of neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Shunt flow in glioblastoma. Study in regional autoregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Renal Arteriovenous Fistula: A Model for Renovascular Hypertension in Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Does angiotensin-II protect against strokes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900687-6

10.1016/S0006-2952(01)00687-6

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference